Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities
Healthcare - Press Releases
Published on Tue 15 Apr 2025 6:36:48 UTC
REAL ID Not Required for Air Travel from May 7th
Published on Tue 15 Apr 2025 6:36:43 UTC
TORRANCE, Calif., April 14, 2025 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the year ended December 31, 2024.
Published on Tue 15 Apr 2025 6:36:39 UTC
FRANKILN, Mass., April 14, 2025 /PRNewswire/ -- Amsino has taken a significant step forward in our mission to advance healthcare worldwide. We are proud to announce the establishment of Amsino Scientific Inc., a new medical device manufacturing, research, and development facility based in Franklin, Massachusetts.
Published on Tue 15 Apr 2025 6:36:34 UTC
INCHEON, South Korea, April 14, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated YUFLYMA (adalimumab-aaty), as an interchangeable biosimilar to Humira (adalimumab). YUFLYMAis an FDA-approved, high-concentration (100mg/mL) and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory indications.[1]
Published on Tue 15 Apr 2025 6:36:32 UTC
To further advance oncology with technology, the biotech startup is setting up a 3D cancer pathology lab in the Phoenix-based Discovery Oasis biotech space.
Published on Tue 15 Apr 2025 6:36:21 UTC
HONG KONG and SHANGHAI, April 14, 2025 /PRNewswire/ -- On April 14, the 2025 Hainan Free Trade Port Global Investment Promotion Conference was held in Haikou. Jointly hosted by the People's Government of Hainan Province and the Ministry of Commerce, the conference is one of the key events in the 2025 "Invest in China" series. With the theme "Invest in Hainan, Connect with the World," the event showcased the achievements, business environment, and investment opportunities of the Hainan Free Trade Port (FTP) to global investors. Wang Qunbin, Co-Chairman of Fosun International, delivered a speech as a representative of key enterprises.
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
Published on Tue 15 Apr 2025 6:36:14 UTC
KYOTO, Japan, April 15, 2025 /PRNewswire/ -- Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tamibarotene-related clinical and non-clinical assets from Syros Pharmaceuticals, Inc. (Headquarters: Boston, MA;NASDAQ:SYRS), through a mutual agreement. The acquisition was completed on February 26, 2025.
Published on Tue 15 Apr 2025 6:36:11 UTC
LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.
Published on Tue 15 Apr 2025 6:36:09 UTC
LONDON, April 15, 2025 /PRNewswire/ -- Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols S.A. to shareholders of Biotest:
Published on Tue 15 Apr 2025 6:36:08 UTC
Acquisition ofTheravia from Mrieux Equity Partners represents meaningful step forward in Norgine's strategy for sustainable growth, adding a complementary portfolio of rare disease medicines
Published on Tue 15 Apr 2025 6:36:04 UTC
VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2024. The annual report is now available on the company's website.
Published on Tue 15 Apr 2025 6:30:03 UTC
Seventh Film in Award-Winning Series Highlights the Heroes on the Front Lines of Health Care
Published on Tue 15 Apr 2025 6:19:56 UTC
Richard Taite, Host of We're Out of Time Podcast (PRNewsfoto/Carrara Treatment Wellness & Spa)
Published on Tue 15 Apr 2025 6:19:46 UTC
Latest edition recognizes nearly 1,900 communities as "best."
Published on Tue 15 Apr 2025 6:17:03 UTC
VANCOUVER, BC, April 15, 2025 /PRNewswire/ -WELL Health Technologies Corp.(TSX: WELL) (the"Company"or"WELL"),a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce it has filed its audited annual financial statements for the fiscal year and fourth quarter ended December 31, 2024, the related management's discussion and analysis ("MD&A"), annual information form, and accompanying CEO and CFO certifications under its profile on SEDAR+ at www.sedarplus.ca.
Published on Fri 11 Apr 2025 6:06:16 UTC
MCKINNEY, Texas, April 10, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) will announce its First Quarter 2025 financial results after the market closes on Wednesday, April 30, 2025.At that time, a copy of the Company's First Quarter 2025 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website, https://investors.globelifeinsurance.com/, under Financial Reports and Other Financial Information.
Published on Fri 11 Apr 2025 6:06:05 UTC
BOSTON, April 10, 2025 /PRNewswire/ -- Intrinsic Therapeutics, a medical technology company driving to change the standard of care for lumbardiscectomy patients with large annular defects by reducing reoperations for reherniations by 81% with its Barricaid Annular Closure Device, today announced the appointment of Keith Valentine as President and Chief Executive Officer. Mr. Valentine will also join the Board of Directors and will begin his role in early May.
Published on Fri 11 Apr 2025 6:05:55 UTC
Merck for Mothers' grant of half a million dollars will help expand the reach of Baby2Baby's initiative to combat the maternal health crisis across the country
Published on Fri 11 Apr 2025 6:05:54 UTC
Company to Participate in Upcoming Conferences
Published on Fri 11 Apr 2025 6:05:49 UTC
BLOOMFIELD, Conn., April 10, 2025 /PRNewswire/ --In an effort to aid local communities impacted by the Southern California wildfires, The Cigna Group and basketball legend Earvin "Magic" Johnson joined forces on a Bright Futures Carnival that provided Boys & Girls Club of Pasadena kids with a fun-filled day of activities, food and gifts - along with a special visit from the basketball legend himself.
Published on Fri 11 Apr 2025 6:05:39 UTC
ST. LOUIS, April 10, 2025 /PRNewswire/ --Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Nevada subsidiary, SilverSummit Healthplan, Inc.(SilverSummit), has been selected by the Nevada Department of Health and Human Services to provide services for its Medicaid managed care program. For the first time the program will include expansion of Medicaid Managed Care into rural and frontier service areas, communities that were previously fee-for-service. Subject to state approval, the five-year contract is expected to begin January 1, 2026, with a possible two-year extension.
Published on Fri 11 Apr 2025 6:05:31 UTC
SAN JUAN, Puerto Rico, April 10, 2025 /PRNewswire/ -- In Puerto Rico, where 90% of the population aged 65 or older takes daily medication, often managing 4 to 5 prescriptions concurrently, medication adherence and safety are paramount. Standardized packaging, while intended to streamline dispensing, can inadvertently lead to confusion, especially at night or during frequent power outages, with residents potentially facing approximately 90 power outages between May and September this year, averaging 18 outages per month.
Published on Fri 11 Apr 2025 6:05:30 UTC
XENICAL remains a well-recognized option for obesity management, offering clinically significant weight loss and metabolic benefits through a unique fat-blocking mechanism. However, its high incidence of gastrointestinal side effects and modest efficacy compared to newer treatments limit its long-term adherence and competitive standing. Despite this, the growing obesity epidemic and XENICAL's established safety profile create opportunities for continued use, particularly in patients who require non-systemic treatment options.
Published on Fri 11 Apr 2025 6:05:19 UTC
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
Published on Fri 11 Apr 2025 6:03:24 UTC
Report Ignores Medicare Contractors' Attack on Patient Care and the Biden Administration's Inaction on Payment Reform
Press Release by Industry
- All Industries
- Agriculture
- Automotive
- Banking
- Business Technology
- Construction
- Consumer Goods
- Consumer Technology
- Education
- Energy
- Entertainment & Media
- Environment
- Financial Services
- Food and Beverage
- General Business
- Healthcare
- Hospitality
- Information Technology
- Insurance
- Heavy Industry & Manufacturing
- Media
- Mining
- People & Culture
- Pharmaceuticals
- Policy & Public Interest
- Real Estate
- Retail
- Sports
- Telecommunications
- Transportation
- Travel
- Utilities